Business Services Industry

HIV drug risk stops trial prematurely.

Australasian Business Intelligence, January, 2006

Byline: Clara Pirani

Jan 19, 2006 (The Australian - ABIX via COMTEX) -- The international Strategies for Management of Anti-Retroviral Therapy trial of HIV/AIDS treatment has had to be abandoned. The group

of patients among the 5,400 participants in 33 nations that received anti-retroviral drugs only intermittently rather than

continuously showed an unacceptably high rate of serious side-effects such as heart, kidney and liver disease. The US National Institutes of Health had funded the research,

designed to establish whether the high costs of treating HIV/AIDS can be lowered by taking drugs only periodically. In Australia, some 200 patients were...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement